Charles Ching


Charles Ching
Charles Ching is a partner in the Corporate Department and heads the Firm’s China practice. He represents financial sponsors and corporate clients on cross-border M&A and investment transactions, with particular focus on private equity investments in China-based businesses, outbound M&A by Chinese buyers, and regional joint ventures and other corporate transactions. He regularly advises China-based clients on some of the most complex and noteworthy public and private M&A transactions in the United States and globally, having practiced previously in New York and Hong Kong.

Mr. Ching is recognized as a leading transactional lawyer by Chambers Asia-Pacific and Legal 500, and is cited as a “Highly Regarded” lawyer for M&A in China by IFLR1000. Chambers noted him for his ability to “find a commercially-balanced solution in complicated situations” and for his “fully attentive and responsive approach”. IFLR1000 referred to him as a “strong communicator, commercially-minded, knowledgeable about the law, responsive/easy to track down”. In addition. Mr. Ching is included in China Business Law Journal’s annual “A-List” for 2018 as one of the leading 50 lawyers in foreign firms in China.

Mr. Ching’s recent representations at Weil include:

  • SoftBank Vision Fund on its US$2 billion investment in Coupang, one of South Korea’s largest online retailers.
  • Warburg Pincus on its investment in Sichuan Jinxin Fertility, one of China’s leading assisted reproduction healthcare providers, and other transactions.
  • Shanghai Pharmaceuticals on its acquisition of US-based Cardinal Health’s pharmaceutical and medical products distribution business in China.
  • Oaktree Capital on the sale of the Axilone business to CITIC Capital.
  • The Learning Lab, a portfolio company of Advent International, on its acquisition of Best Learning, an English language training (ELT) institute for juniors in China.
  • HNA Group on its US$6.5 billion acquisition of a 25% stake in Hilton Worldwide Holdings from Blackstone.
  • Advent International on its acquisition of a majority stake in King Koil Shanghai Sleep System, a leading, premium manufacturer and retailer of mattresses in China, from CITIC Capital.
  • Primavera Capital on its investment in Koubei, an on-demand local services platform in China and other transactions.
  • HNA Group and Tianjin Tianhai Investment Company on their US$6 billion acquisition of US-listed Ingram Micro, an IT logistics and solutions provider.
  • Avolon Holdings, an aircraft leasing and management services provider, on the US$2.6 billion acquisition of the company by Bohai Leasing.

Mr. Ching is qualified in New York and Hong Kong. He is a native Mandarin speaker.